ESR1 and breast carcinoma: Moreover, the invasive ability of 4T1 cell was not altered by Dex (Fig. 2E), and irrespective of estrogen receptor (ER) status, Dex treatment did not affect the proliferation and colony-forming capacities of breast cancer cells in the absence of estrogen stimulation (Supplementary Fig. S2A, B).